India, March 12 -- Smiths Medical, affiliated to infusion therapy company ICU Medical, Inc., has called back various sizes of Intubation ORAL/NASAL Endotracheal Tube products for an urgent medical device correction, according to the U.S. Food and Drug Administration.
The 2.0, 2.5, 3.0 and 3.5 mm sizes of Intubation ORAL/NASAL Endotracheal Tube products are being smaller than expected, which could result in serious injury.
The impacted products were manufactured from October 01, 2019 to October 03, 2024 and distributed from October 30, 2019 to December 16, 2024.
The device's diameter, if smaller than expected, may potentially result in inadequate ventilation to the patient, post-insertion of the endotracheal tube. In such situations, the ...